BRIEF published on 02/25/2026 at 09:05, 8 months 9 days ago Hoenle AG Reports Positive Q1 Results Amid Mixed Segment Performance Revenue Market Expansion Q1 Results Hoenle AG Disinfection Growth
PRESS RELEASE published on 02/25/2026 at 09:00, 8 months 9 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Hoenle AG's Q1 results for FY 25/26: Revenue flat at €21.5m, strong Disinfection growth, Curing weak. EBITDA ahead at €0.5m. Expecting growth in revenue & EBITDA for FY 25/26 EBITDA Q1 Results Disinfection Hoenle AG FY 25/26
BRIEF published on 02/02/2026 at 09:05, 9 months 4 days ago Hoenle AG Forecasts Growth Amid Challenging Market Conditions Revenue Growth Market Outlook EBITDA Improvement Hoenle AG FY 24/25 Earnings
PRESS RELEASE published on 02/02/2026 at 09:00, 9 months 4 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Hoenle AG's research update by NuWays AG reveals FY 24/25 results and FY 25/26 expectations, highlighting revenue and EBITDA trends across Disinfection, Adhesives, and Curing segments NuWays AG Research Update Hoenle AG FY 24/25 Results FY 25/26 Expectations
BRIEF published on 12/10/2025 at 09:05, 10 months 27 days ago Hoenle AG: Strategic Advances Amid Challenging Market Conditions Growth Strategy Financial Forecast Market Leadership UV Technology Hoenle AG
PRESS RELEASE published on 12/10/2025 at 09:00, 10 months 27 days ago Original-Research: Hoenle AG (von NuWays AG): BUY NuWays AG updates research on Hoenle AG, recommending BUY with a target price of EUR 15.00. Hoenle leads in UV curing devices, offering solutions in adhesives, curing, and disinfection, focusing on niche markets Investment NuWays AG Research Hoenle AG UV Curing
BRIEF published on 12/03/2025 at 09:05, 11 months 3 days ago Hoenle AG Poised for Growth Amid Strategic Shifts EBITDA Margin Sales Growth Strategic Transformation Hoenle AG Disinfection Business
PRESS RELEASE published on 12/03/2025 at 09:00, 11 months 3 days ago Original-Research: Hoenle AG (von NuWays AG): BUY Update on Hoenle AG by NuWays AG highlighting FY24/25 figures meeting guidance, FY25/26 growth expectations, strong EBITDA margin, and long-term prospects. Company poised for strategic transformation EBITDA Margin NuWays AG FY24/25 Hoenle AG FY25/26
Published on 11/06/2026 at 22:15, 8 hours 6 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 17 hours 21 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 17 hours 51 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 17 hours 51 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 10 hours 6 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 11 hours 6 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 11 hours 21 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 11 hours 49 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 12 hours 21 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 12 hours 21 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 12 hours 27 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 12 hours 46 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
